Moderna doubles in share price after making progress in unique Cancer cure

Moderna’s share price more than doubled during yesterday’s market session in the US after it announced major progress with its personalised cancer treatment. Shares surged by as much as 160% during trading after Moderna and Merck announced positive results from a Phase 3 trial of their experimental mRNA cancer vaccine, intismeran autogene. Moderna’s new treatment […] The post Moderna doubles in…